Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 June 2020 | Story Nitha Ramnath | Photo Supplied
Mischke Bouwer.

Mischke Bouwer was recently awarded a Fulbright scholarship to study her PhD in Geoscience at the Southern Illinois University (SIU). The duration of the programme at SIU is five years, starting in August 2020.

Fulbright is a scholarship programme that recruits students from all over the world in any field of study to do their postgraduate studies in America. This is done through funding from Fulbright, together with the country's government and American universities. 

“This is not only a funding scholarship, but a supportive community! It really does feel like teamwork so far. The people from Fulbright ensure that the students feel as comfortable and enlightened as possible when leaving the country, and I am sure it will be the same when I arrive in America,” says Mischke.

Mischke considers herself an average girl who grew up in Pretoria; she enrolled at the UFS for a BSc in Geology from 2014 to 2016, followed by an Honours in Geology in 2017, and MSc in Soil Science. 
“I took a big chance by applying for a Fulbright scholarship but did not expect anything, as I felt I would never be good enough – but look where I am now,” says Mischke.

“I am speechless about the scholarship I received. There are many people I would like to thank who helped me along the way to achieve this scholarship. I would love this opportunity to thank all my lecturers from the UFS, both in the departments of Geology and Soil Science. Thanks to my supervisors for always believing in me. A special thanks to Prof Cornie van Huyssteen who was fully behind me, impacting my way of thinking, and teaching me a lot in two years.”

Mischke dedicates this scholarship to the late Prof Marian Tredoux, a true scientist and lecturer in the Department of Geology, who not only contributed greatly to the sciences, but truly impacted her students. “She inspired me to work hard and showed me an example of what a woman in science could be,” says Mischke.

She encourages students to apply for this scholarship, adding that there is nothing to lose. According to Mischke, students are much smarter than they would like to believe and should therefore always be mindful that their future is way brighter than they think.

“Make your role model YOU in 10 years and keep it that way! This way you always have someone to strive for!” says Mischke.

Mischke works on the absorption potential of arsenic and selenium in the field of environmental geochemistry and geochemical modelling. She hopes to return to South Africa with this knowledge and to make a difference in the remediation and rehabilitation of mines. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept